Crystal structures of the free and liganded form of an esterolytic catalytic antibody

Journal of Molecular Biology

Volumn 268, Issue 2, 1997, Pages 390-400

  Wedemayer, Gary J ^a   Wang, Leo H ^a   Patten, Phillip A ^a   Schultz, Peter G ^a   Stevens, Raymond C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody; Catalysis; Crystal structure; Esterolytic

Indexed keywords

ANTIBODY; CATALYTIC ANTIBODY; ESTERASE; HAPTEN;

ANTIBODY STRUCTURE; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031547956     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.0974     Document Type: Article

References (55)

1. Alzari P. M., Spinelli S., Mariuzza R. A., Boulot G., Poljak R. J., Jarvis J. M., Milstein C. Three-dimensional structure of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response. EMBO J. 9:1990;3807-3814.
2. Arevalo J. H., Stura E. A., Taussig M. J., Wilson I. A. Three-dimensional structure of an anti-steroid Fab′ and progesterone-Fab′ complex. J. Mol. Biol. 231:1993a;103-118.
3. Arevalo J. H., Taussig M. J., Wilson I. A. Molecular basis of cross-reactivity and the limits of antibody-antigen complementarity. Nature. 365:1993b;859-863.
4. Arevalo J. H., Hassig C. A., Stura E. A., Sims M. J., Taussig M. J., Wilson I. A. Structural analysis of antibody specificity. Detailed comparison of five Fab′-steroid complexes. J. Mol. Biol. 241:1994;663-690.
5. Bhat T. N., Bentley G. A., Fischmann T. O., Boulot G., Poljak R. J. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature. 34:1990;483-485.
6. Brünger A. T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992a;472-475.
7. Brünger A. T. X-PLOR Manual version 3.1, Yale University Press, New Haven and London. 1992b.
8. Brünger A. T. X-PLOR- A system for crystallography and NMR 3.1, Yale University Press, New Haven. 1992c.
9. Brünger A. T., Krukowski A., Erickson J. W. Slow cooling protocols for crystallographic refinement by simulated annealing. Acta Crystallog. sect. A. 46:1990;583-593.
10. Brünger A. T., Leahy D. J., Hynes T. R., Fox R. O. A 2.9 Å resolution structure of an anti dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten. J. Mol. Biol. 221:1991;239-256.
11. Charbonnier J. B., Carpenter E., Gigant B., Golinelli-Pimpaneau B., Eshhar Z., Green B. S., Knossow M. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Proc. Natl Acad. Sci. USA. 92:1995;11721-11725.
12. Chitarra V., Alzari P. M., Bentley G. A., Bhat T. N., Eisele J., Houdusse A., Lescar J., Souchon H., Poljak R. J. Three-dimensional structure of a heteroclitic antibody-antigen cross-reaction complex. Proc. Natl Acad. Sci. USA. 90:1993;7711-7715.
13. Acta Crystallog. sect. D. 50:1994;760-763.
14. Colman P. M. Structure of antibody-antigen complexes: implications for immune recognition. Advan. Immunol. 43:1988;99-132.
15. HER2antibody 4D5 and comparison with molecular modeling. J. Mol. Biol. 229:1993;969-995.
16. Fischmann T. O., Bentley G. A., Bhat T. N., Boulot G., Mariuzza R. A., Phillops S. V., Tello D., Poljak R. J. Crystallographic refinement of the three-dimensional structure of the Fab D1.3-lysozyme complex at 2.5 Å resolution. J. Biol. Chem. 266:1991;12915-12920.
17. Fujinaga M., James M. N. Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 Å resolution. J. Mol. Biol. 195:1987;373-396.
18. Golinelli-Pimpaneau B., Gigant B., Bizebard T., Navaza J., Saludjian P., Zemel R., Tawfik D. S., Eshhar Z., Green B. S., Knossow M. Crystal structure of a catalytic antibody Fab with esterase-like activity. Structure. 2:1994;175-183.
19. Guddat L. W., Shan L., Anchin J. M., Linthicum D. S., Edmundson A. B. Local and transmitted conformational changes on complexation of an anti-sweetener Fab. J. Mol. Biol. 236:1994;247-274.
20. Haynes M. R., Stura E. A., Hilvert D., Wilson I. A. Crystallization and preliminary structural studies of a chorismate mutase catalytic antibody complexed with a transition state analog. Proteins: Struct. Funct. Genet. 18:1994a;198-200.
21. Haynes M. R., Stura E. A., Hilvert D., Wilson I. A. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart. Science. 263:1994b;646-652.
22. Herron J. N., He X. M., Mason M. L., Voss E. W., Jr, Edmondson A. B. Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol. Proteins: Struct. Funct. Genet. 5:1989;271-280.
23. Herron J. N., He X. M., Ballard D. W., Blier P. R., Pace P. E., Bothwell A. L. M., Voss E. W., Jr, Edmundson A. B. An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex. Proteins: Struct. Funct. Genet. 11:1991;159-175.
24. Hsieh-Wilson L., Schultz P. G., Stevens R. C. Insights into antibody catalysis: structure of an oxygenation catalyst at 1.9 Å resolution. Proc. Natl Acad. Sci. USA. 93:1996;5363-5367.
25. Ippolito J. A., Alexander R. S., Christianson D. W. Hydrogen bond stereochemistry in protein structure and function. J. Mol. Biol. 215:1990;457-471.
26. Jacobs, J. W. 1990, Catalytic antibodies, PhD, University of California, Berkeley.
27. Jancarik J., Kim S. H. Sparse matrix sampling: a screening method for crystallization of proteins. J. Appl. Crystallog. 24:1991;409-411.
28. Jeffrey G. A., Saenger W. Hydrogen Bonding in Biological Structures. 1991;Springer-Verlag Publ. Berlin, Heidelberg and New York.
29. Jeffrey P. D., Strong R. K., Sieker L. C., Chang C. Y. Y., Campbell R. L., Petsko G. A., Haber E., Margolies M. N., Sheriff S. 26-10 Fab-digoxin complex: affinity and specifity due to surface complementarity. Proc. Natl Acad. Sci. USA. 90:1993;10310-10314.
30. Jencks W. P. Catalysis in Chemistry and Enzymology. 1969;McGraw-Hill, New York.
31. Jones T. A., Zou J.-Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
32. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Sequences of Proteins of Immunological Interest. 1991;U.S. Dept. of Health and Human Services, Washington, DC.
33. Kraulis P. J. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
34. Laskowski R. A., MacArthur M. W., Moss D. S., Thorton J. M. PROCHECK: a program to check the stereochemistry quality of protein structures. J. Appl. Crystallog. 26:1993;282-291.
35. Lerner R., Benkovic S. J., Schultz P. G. At the crossroads of chemistry and immunology: catalytic antibodies. Science. 252:1991;659-667.
36. Lesley S. A., Patten P. A., Schultz P. G. A genetic approach to the generation of antibodies with enhanced catalytic activities. Proc. Natl Acad. Sci. USA. 90:1993;1060-1065.
37. Navaza J. AMORE molecular replacement package. Acta Crystallog. sect. A. 50:1994;157-163.
38. Padlan E. A., Silverton E. W., Sheriff S., Cohen G. H., Smith-Gill S. J., Davies D. R. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc. Natl Acad. Sci. USA. 86:1989;5938-5942.
39. Patten P. A., Gray N. S., Yang P. L., Marks C. B., Wedemayer G. J., Boniface J. J., Stevens R. C., Schultz P. G. The immunological evolution of catalysis. Science. 271:1996;1086-1091.
40. Pauling L. Chemical achievement and hope for the future. Am. Sci. 36:1948;51-58.
41. Pollack S. J., Jacobs J. W., Schultz P. G. Selective chemical catalysis by an antibody. Science. 234:1986;1570-1573.
42. Rini J. M., Schulze-Gahmen U., Wilson I. A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 255:1992;959-965.
43. Rini J. M., Stanfield R. L., Stura E. A., Salinas P. A., Profy A. T., Wilson I. A. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl Acad. Sci. USA. 90:1993;6325-6329.
44. Roberts V. A., Stewart J., Benkovic S. J., Getzoff E. D. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. J. Mol. Biol. 253:1994;1098-1116.
45. Schildbach J. F., Near R. I., Bruccoleri R. E., Haper E., Jeffrey P. D., Novotny J., Sheriff S., Margolies M. N. Modulation of antibody affinity by a non-contact residue. Protein Sci. 2:1993;206-214.
46. Sheriff S., Hendrickson W. A., Smith J. L. Structure of the myohemerythrin in the azidomet state at 1.7/1.3 Å resolution. J. Mol. Biol. 197:1987;273-296.
47. Shoham M. Crystal structure of an anticholera toxin peptide complex at 2.3 Å J. Mol. Biol. 232:1993;1169-1175.
48. Stanfield R. L., Fieser T. M., Lerner R. A., Wilson I. A. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å Science. 248:1990;712-719.
49. Stanfield R. L., Takimoto-Kamimura M., Rini J. M., Profy A. T., Wilson I. A. Major antigen-induced domain rearrangements in an antibody. Structure. 1:1993;83-93.
50. Tramontano A., Janda K. D., Lerner R. A. Catalytic antibodies. Science. 234:1986;1566-1570.
51. Tulip W. R., Varghese J. N., Laver W. G., Webster R. G., Colman P. M. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J. Mol. Biol. 227:1992;122-148.
52. Webster D. M., Henry A. H., Rees A. R. Antibody-antigen interactions. Curr. Opin. Struct. Biol. 4:1994;123-129.
53. Wilson I. A., Stanfield R. L. Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3:1993;113-118.
54. Wilson I. A., Stanfield R. L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4:1994;857-867.
55. Zhou G. W., Huang W., Fletterick R. J., Scanlan T. S. Crystal structure of a catalytic antibody with a serine protease active site. Science. 265:1994;1059-1064.